Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management options after prophylactic surgeries in women with BRCA mutations: a review.

Cancer control : journal of the Moffitt Cancer Center - 1 Oct 2007

Allain Dawn C, Sweet Kevin, Agnese Doreen M

Abstract excerpt

BACKGROUND: Although breast cancer is relatively common, only about 5% of cases are due to inheritance of highly penetrant cancer susceptibility genes. The majority of these are caused by mutations in the BRCA1 and BRCA2 genes, which are also associated with an increased risk of ovarian cancer. Increased surveillance, chemoprevention, and prophylactic surgeries are standard options for the effective medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Chemoprevention
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Mass Screening

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 17914333
DOI: 10.1177/107327480701400403

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management options after prophylactic surgeries in women with BRCA mutations: a review.PMID 17914333Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Prophylactic breast surgery for women with BRCA1 and BRCA2 germline mutations.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.Semantic proximity Read ↗

Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Semantic proximity Read ↗

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.Semantic proximity Read ↗

The counseling and management of young healthy BRCA mutation carriers.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Treatment of women with BRCA mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.